Karim Bitar

Karim joined ConvaTec in September 2019. Previously, he was CEO of Genus plc, a leading global agricultural biotechnology company. During his eight-year tenure, he helped transform Genus into a technology pioneer with leading global franchises in dairy, beef, and pork genetics. Prior to this, Karim worked for over 15 years with Eli Lilly & Company and was President of Lilly Europe, Canada, and Australia before joining Genus. An ex-McKinsey & Company consultant, he has worked across Asia and Europe, and also held management roles at Johnson & Johnson and the Dow Chemical Company.

Karim was a Non-Executive Director of Spectris Plc, a leading global analytical instrumentation company, from June 2017 to January 2022, and is a member of the University of Michigan Ross School of Business Advisory Board.

Karim has a Masters (Hons) in Business Administration, from the University of Michigan, Ross School of Business, and a Bachelor of Science in Biochemistry, from the University of Wisconsin.